| GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score JD Yang, BD Addissie, KC Mara, WS Harmsen, J Dai, N Zhang, ... Cancer Epidemiology, Biomarkers & Prevention 28 (3), 531-538, 2019 | 186 | 2019 |
| Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype SR Senum, YSM Li, KA Benson, G Joli, E Olinger, S Lavu, CD Madsen, ... The American Journal of Human Genetics 109 (1), 136-156, 2022 | 92 | 2022 |
| Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease K Hopp, E Cornec-Le Gall, SR Senum, IBAW Te Paske, S Raj, S Lavu, ... Kidney international 97 (2), 370-382, 2020 | 66 | 2020 |
| The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD S Lavu, LE Vaughan, SR Senum, TL Kline, AB Chapman, RD Perrone, ... JCI insight 5 (15), 2020 | 60 | 2020 |
| Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients N Fan, S Lavu, CA Hanson, A Tefferi Blood cancer journal 8 (12), 119, 2018 | 55 | 2018 |
| JAK2 exon 12 mutated polycythemia vera: Mayo‐Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease A Tefferi, S Lavu, M Mudireddy, TL Lasho, CM Finke, N Gangat, ... American journal of hematology 93 (4), E93-E96, 2018 | 42 | 2018 |
| Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: the Mayo clinic experience with 84 consecutive cases S Lavu, N Szuber, M Mudireddy, M Yogarajah, N Gangat, A Pardanani, ... American journal of hematology 93 (3), E61-E64, 2018 | 35 | 2018 |
| Effect of statins on the risk of extrahepatic cholangiocarcinoma S Lavu, TM Therneau, WS Harmsen, KC Mara, N Wongjarupong, ... Hepatology 72 (4), 1298-1309, 2020 | 22 | 2020 |
| Potential role of inflammation-promoting biliary microbiome in primary sclerosing cholangitis and cholangiocarcinoma K Miyabe, V Chandrasekhara, N Wongjarupong, J Chen, L Yang, ... Cancers 14 (9), 2120, 2022 | 18 | 2022 |
| Characteristics of patients with end-stage kidney disease in ADPKD SS Shukoor, LE Vaughan, ME Edwards, S Lavu, TL Kline, SR Senum, ... Kidney International Reports 6 (3), 755-767, 2021 | 15 | 2021 |
| Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates N Szuber, S Lavu, M Mudireddy, M Nicolosi, D Penna, RR Vallapureddy, ... Blood cancer journal 8 (12), 118, 2018 | 11 | 2018 |
| Detection of cholangiocarcinoma by assay of methylated DNA markers in plasma JD Yang, TC Yab, WR Taylor, PH Foote, HA Ali, S Lavu, JA Simonson, ... Gastroenterology 152 (5), S1041-S1042, 2017 | 8 | 2017 |
| HALT Progression of Polycystic Kidney Disease Group, the ADPKD Modifier Study: Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease K Hopp, E Cornec-Le Gall, SR Senum, I Te Paske, S Raj, S Lavu, ... Kidney Int 97 (370-382), 31874800, 2020 | 7 | 2020 |
| Cardiac tamponade in myelofibrosis: a Mayo clinic series of nine consecutive cases S Lavu, A Tefferi American journal of hematology 92 (9), E544-E545, 2017 | 2 | 2017 |
| JAK2 exon 12 mutated polycythemia vera: the Mayo Clinic-University of Florence experience with 33 consecutive cases and comparison with JAK2 V617F mutated disease A Tefferi, S Lavu, TL Lasho, C Finke, N Gangat, A Pardanani, CA Hanson, ... Blood 130, 4191, 2017 | 1 | 2017 |
| Splanchnic Vein Thrombosis in Overt Myeloproliferative Neoplasms: The Mayo Clinic Experience with 107 Unselected Consecutive Cases S Lavu, N Gangat, A Pardanani, CA Hanson, RP Ketterling, AA Ashrani, ... Blood 130, 2925, 2017 | 1 | 2017 |
| Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma S Lavu, N Wongjarupong, S Antwi, HA Ali, F Hassan, H Ali, NH Giama, ... HEPATOLOGY 66, 760A-760A, 2017 | | 2017 |
| Detection and Characterization of Mosaicism in Autosomal Dominant Polycystic Kidney Disease (ADPKD) kidney International, 0 | | |
